Iranian Registry of Crohn’S and Colitis: Study Profile of First Nation-Wide Inflammatory Bowel Disease Registry in Middle East

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Iranian Registry of Crohn’S and Colitis: Study Profile of First Nation-Wide Inflammatory Bowel Disease Registry in Middle East Publisher

Malekzadeh MM¹ ; Sima A¹ ; Alatab S¹ ; Sadeghi A¹ ; Daryani NE² ; Adibi P³ ; Maleki I⁴ ; Vossoughinia H⁵ ; Fakheri H⁴ ; Yazdanbod A⁶ ; Taghavi SA⁷ ; Aghazadeh R⁸ ; Somi MH⁹ ; Zendedel K^{10, 11} Show All Authors

Malekzadeh MM¹
Sima A¹
Alatab S¹
Sadeghi A¹
Daryani NE²
Adibi P³
Maleki I⁴
Vossoughinia H⁵
Fakheri H⁴
Yazdanbod A⁶
Taghavi SA⁷
Aghazadeh R⁸
Somi MH⁹
Zendedel K^{10, 11}
Vahedi H¹
Malekzadeh R¹

Source: Intestinal Research Published:2019

Abstract

Background/Aims: A recent study revealed increasing incidence and prevalence of inflammatory bowel disease (IBD) in Iran. The Iranian Registry of Crohn’s and Colitis (IRCC) was designed recently to answer the needs. We reported the design, methods of data collection, and aims of IRCC in this paper. Methods: IRCC is a multicenter prospective registry, which is established with collaboration of more than 100 gastroenterologists from different provinces of Iran. Minimum data set for IRCC was defined according to an international consensus on standard set of outcomes for IBD. A pilot feasibility study was performed on 553 IBD patients with a web-based questionnaire. The reliability of questionnaire evaluated by Cronbach’s α. Results: All sections of questionnaire had Cronbach’s α of more than 0.6. In pilot study, 312 of participants (56.4%) were male and mean age was 38 years (standard deviation= 12.8) and 378 patients (68.35%) had ulcerative colitis, 303 subjects (54,7%) had college education and 358 patients (64.74%) were of Fars ethnicity. We found that 68 (12.3%), 44 (7.9%), and 13 (2.3%) of participants were smokers, hookah and opium users, respectively. History of appendectomy was reported in 58 of patients (10.48%). The most common medication was 5-aminosalicylate (94.39%). Conclusions: To the best of our knowledge, IRCC is the first national IBD registry in the Middle East and could become a reliable infrastructure for national and international research on IBD. IRCC will improve the quality of care of IBD patients and provide national information for policy makers to better plan for controlling IBD in Iran. (Intest Res 2019;17:330-339) © Copyright 2019. Korean Association for the Study of Intestinal Diseases. All rights reserved

Related Docs

View other Related Docs

1. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (Ircc), Archives of Iranian Medicine (2024)

2. Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-Wide Study From Iran, Archives of Iranian Medicine (2016)

3. Inflammatory Bowel Disease Registry and Monitoring: Feasibility Study and Application (Isfahan Inflammatory Bowel Disease Surveillance Project), International Journal of Preventive Medicine (2019)

Experts (# of related papers)

View all Related Experts

Peyman Adibi (12)

Hamed Daghaghzadeh (5)

Other Related Docs

4. Evaluation of the Association Between Periodontitis and Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis, BMC Gastroenterology (2025)

5. Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term Nsaids With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (Pure) Study, Clinical Gastroenterology and Hepatology (2023)

6. Association Between Food-Based Dietary Inflammatory Potential and Ulcerative Colitis: A Case–Control Study, Scientific Reports (2023)

7. A Population Based Case–Control Study of Association Between Dietary Calcium Intake and Ulcerative Colitis in Adults, Scientific Reports (2022)

8. Psychometric Characteristics of the Persian Version of the Irritable Bowel Syndrome Quality of Life Questionnaire (P-Ibs-Qol), Pakistan Journal of Medical Sciences (2012)

9. Determining Guidelines for Local Ambulatory Care During Flare-Ups of Mild to Moderate Ulcerative Colitis for Effective Control of the Disease at Home, Journal of Isfahan Medical School (2025)

10. Linguistic Validation of the Inflammatory Bowel Disease Questionnaire-Short Form (Ibdq-9) in Iranian Population, Journal of Isfahan Medical School (2011)

11. Food Item Avoidance of Patients With Irritable Bowel Syndrome Compared With Healthy People, Archives of Iranian Medicine (2019)

12. Linguistic Validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian Patients, Acta Medica Iranica (2011)

13. Empirically Derived Food-Based Inflammatory Potential of the Diet, Irritable Bowel Syndrome, and Its Severity, Nutrition (2019)

14. Genomic Testing Identifies Monogenic Causes in Patients With Very Early-Onset Inflammatory Bowel Disease: A Multicenter Survey in an Iranian Cohort, Clinical and Experimental Immunology (2024)

15. Quality of Life in Inflammatory Bowel Disease Patients: A Cross-Sectional Study, Journal of Research in Medical Sciences (2017)

16. Association of Dietary Fiber, Fruit, and Vegetable Consumption With Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis, Advances in Nutrition (2021)

17. Adherence to the Pro-Inflammatory Diet in Relation to Prevalence of Irritable Bowel Syndrome, Nutrition Journal (2019)

18. Relative Frequency of Gastrointestinal Functional Disorders in Patients With Inflammatory Bowel Disease Based on Rome Iv: A Case-Control Study, Advanced Biomedical Research (2024)

19. The Association of Irritable Bowel Syndrome and Obesity in Iranian Adults, Journal of Isfahan Medical School (2016)

20. The Prevalence of Adherent-Invasive Escherichia Coli and Its Association With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis, Frontiers in Medicine (2021)

Style	Citing Format
MLA	Malekzadeh MM, et al.. "Iranian Registry of Crohn’S and Colitis: Study Profile of First Nation-Wide Inflammatory Bowel Disease Registry in Middle East." Intestinal Research, vol. 17, no. 3, 2019, pp. 330-339.
APA	Malekzadeh MM, Sima A, Alatab S, Sadeghi A, Daryani NE, Adibi P, Maleki I, Vossoughinia H, Fakheri H, Yazdanbod A, Taghavi SA, Aghazadeh R, Somi MH, Zendedel K, Vahedi H, Malekzadeh R (2019). Iranian Registry of Crohn’S and Colitis: Study Profile of First Nation-Wide Inflammatory Bowel Disease Registry in Middle East. Intestinal Research, 17(3), 330-339.
Chicago	Malekzadeh MM, Sima A, Alatab S, Sadeghi A, Daryani NE, Adibi P, Maleki I, et al.. "Iranian Registry of Crohn’S and Colitis: Study Profile of First Nation-Wide Inflammatory Bowel Disease Registry in Middle East." Intestinal Research 17, no. 3 (2019): 330-339.
Harvard	Malekzadeh MM et al. (2019) 'Iranian Registry of Crohn’S and Colitis: Study Profile of First Nation-Wide Inflammatory Bowel Disease Registry in Middle East', Intestinal Research, 17(3), pp. 330-339.
Vancouver	Malekzadeh MM, Sima A, Alatab S, Sadeghi A, Daryani NE, Adibi P, et al.. Iranian Registry of Crohn’S and Colitis: Study Profile of First Nation-Wide Inflammatory Bowel Disease Registry in Middle East. Intestinal Research. 2019;17(3):330-339.
BibTex	@article{ author = {Malekzadeh MM and Sima A and Alatab S and Sadeghi A and Daryani NE and Adibi P and Maleki I and Vossoughinia H and Fakheri H and Yazdanbod A and Taghavi SA and Aghazadeh R and Somi MH and Zendedel K and Vahedi H and Malekzadeh R}, title = {Iranian Registry of Crohn’S and Colitis: Study Profile of First Nation-Wide Inflammatory Bowel Disease Registry in Middle East}, journal = {Intestinal Research}, volume = {17}, number = {3}, pages = {330-339}, year = {2019} }
RIS	TY - JOUR AU - Malekzadeh MM AU - Sima A AU - Alatab S AU - Sadeghi A AU - Daryani NE AU - Adibi P AU - Maleki I AU - Vossoughinia H AU - Fakheri H AU - Yazdanbod A AU - Taghavi SA AU - Aghazadeh R AU - Somi MH AU - Zendedel K AU - Vahedi H AU - Malekzadeh R TI - Iranian Registry of Crohn’S and Colitis: Study Profile of First Nation-Wide Inflammatory Bowel Disease Registry in Middle East JO - Intestinal Research VL - 17 IS - 3 SP - 330 EP - 339 PY - 2019 ER -